| Literature DB >> 22079865 |
Claudia Bello1, Giovanna Dal Bello, Michele Cea, Aimable Nahimana, Dominique Aubry, Anna Garuti, Giulia Motta, Eva Moran, Floriana Fruscione, Paolo Pronzato, Francesco Grossi, Franco Patrone, Alberto Ballestrero, Marc Dupuis, Bernard Sordat, Kaspar Zimmermann, Jacqueline Loretan, Markus Wartmann, Michel A Duchosal, Alessio Nencioni, Pierre Vogel.
Abstract
New derivatives of 1,4-dideoxy-1,4-imino-D-ribitol have been prepared and evaluated for their cytotoxicity on solid and haematological malignancies. 1,4-Dideoxy-5-O-[(9Z)-octadec-9-en-1-yl]-1,4-imino-D-ribitol (13, IC(50) ∼2 μM) and its C(18)-analogues (IC(50) <10 μM) are cytotoxic toward SKBR3 (breast cancer) cells. 13 also inhibits (IC(50) ∼8 μM) growth of JURKAT cells.Entities:
Mesh：
Substances：
Year: 2011 PMID： 22079865 DOI： 10.1016/j.bmc.2011.07.053
Source DB: PubMed Journal: Bioorg Med Chem ISSN： 0968-0896 Impact factor: 3.641